Itolerance, Inc
iTolerance is a privately held regenerative medicine company focused on tissue, organoid, or cell therapy without life-long immunosuppression.
- Headquarters
- Miami, Florida, United StatesSource: RevenueBaseRetrieved October 13, 2026
- Employee range
- 1 to 10Source: RevenueBaseRetrieved October 13, 2026
- Founded
- 2020Source: RevenueBaseRetrieved October 13, 2026
- Published list appearances
- 4 supported appearances ↗Source: RevenueBase lists
What does Itolerance, Inc do?
The company is advancing programs using allogenic pancreatic islets and stem cells. Its lead program, iTOL-101, is being developed for Type 1 diabetes.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Company lists.
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Share your recognition
Embeddable award for your website
Sources & data notes.
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 14, 2026, September 18, 2026, October 7, 2026 and October 8, 2026. How the company lists are built.
Something changed?
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
One company is just the start.
Explore more companies by name, headquarters and business focus.